Vitamin K Antagonists (VKA) Market Report

Global Vitamin K Antagonists (VKA) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 11, 2022
  • PAGES：209
  • REPORT CODE：GMM812069
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Vitamin K Antagonists (VKA) market report explains the definition, types, applications, major countries, and major players of the Vitamin K Antagonists (VKA) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Lilly

    • Bristol-Myers Squibb

    • The Medicines Company

    • Boehringer Ingelheim

    • Genentech (Roche)

    • Johnson & Johnson

    • Aspen

    • Bayer

    • Daiichi Sankyo

    • Otsuka

    • Sanofi

    • AstraZeneca

    • Pfizer

    By Type:

    • Oral Vitamin K Antagonists

    • Injection Vitamin K Antagonists

    By End-User:

    • VTE

    • ACS/MI

    • AF

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Vitamin K Antagonists (VKA) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Vitamin K Antagonists (VKA) Outlook to 2028- Original Forecasts

    • 2.2 Vitamin K Antagonists (VKA) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Vitamin K Antagonists (VKA) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Vitamin K Antagonists (VKA) Market- Recent Developments

    • 6.1 Vitamin K Antagonists (VKA) Market News and Developments

    • 6.2 Vitamin K Antagonists (VKA) Market Deals Landscape

    7 Vitamin K Antagonists (VKA) Raw Materials and Cost Structure Analysis

    • 7.1 Vitamin K Antagonists (VKA) Key Raw Materials

    • 7.2 Vitamin K Antagonists (VKA) Price Trend of Key Raw Materials

    • 7.3 Vitamin K Antagonists (VKA) Key Suppliers of Raw Materials

    • 7.4 Vitamin K Antagonists (VKA) Market Concentration Rate of Raw Materials

    • 7.5 Vitamin K Antagonists (VKA) Cost Structure Analysis

      • 7.5.1 Vitamin K Antagonists (VKA) Raw Materials Analysis

      • 7.5.2 Vitamin K Antagonists (VKA) Labor Cost Analysis

      • 7.5.3 Vitamin K Antagonists (VKA) Manufacturing Expenses Analysis

    8 Global Vitamin K Antagonists (VKA) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Vitamin K Antagonists (VKA) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Vitamin K Antagonists (VKA) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Vitamin K Antagonists (VKA) Market Outlook by Types and Applications to 2022

    • 9.1 Global Vitamin K Antagonists (VKA) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Vitamin K Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Vitamin K Antagonists Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vitamin K Antagonists (VKA) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global VTE Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global ACS/MI Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global AF Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Vitamin K Antagonists (VKA) Market Analysis and Outlook till 2022

    • 10.1 Global Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.2.2 Canada Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.2.3 Mexico Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.2 UK Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.3 Spain Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.4 Belgium Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.5 France Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.6 Italy Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.7 Denmark Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.8 Finland Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.9 Norway Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.10 Sweden Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.11 Poland Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.12 Russia Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.3.13 Turkey Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.2 Japan Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.3 India Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.4 South Korea Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.5 Pakistan Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.6 Bangladesh Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.7 Indonesia Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.8 Thailand Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.9 Singapore Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.10 Malaysia Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.11 Philippines Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.4.12 Vietnam Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.2 Colombia Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.3 Chile Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.4 Argentina Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.5 Venezuela Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.6 Peru Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.5.8 Ecuador Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.6.2 Kuwait Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.6.3 Oman Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.6.4 Qatar Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.7.2 South Africa Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.7.3 Egypt Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.7.4 Algeria Vitamin K Antagonists (VKA) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Vitamin K Antagonists (VKA) Consumption (2017-2022)

      • 10.8.2 New Zealand Vitamin K Antagonists (VKA) Consumption (2017-2022)

    11 Global Vitamin K Antagonists (VKA) Competitive Analysis

    • 11.1 Lilly

      • 11.1.1 Lilly Company Details

      • 11.1.2 Lilly Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Lilly Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.1.4 Lilly Vitamin K Antagonists (VKA) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bristol-Myers Squibb

      • 11.2.1 Bristol-Myers Squibb Company Details

      • 11.2.2 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 The Medicines Company

      • 11.3.1 The Medicines Company Company Details

      • 11.3.2 The Medicines Company Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 The Medicines Company Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.3.4 The Medicines Company Vitamin K Antagonists (VKA) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Boehringer Ingelheim

      • 11.4.1 Boehringer Ingelheim Company Details

      • 11.4.2 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.4.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Genentech (Roche)

      • 11.5.1 Genentech (Roche) Company Details

      • 11.5.2 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Johnson & Johnson

      • 11.6.1 Johnson & Johnson Company Details

      • 11.6.2 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Johnson & Johnson Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.6.4 Johnson & Johnson Vitamin K Antagonists (VKA) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Aspen

      • 11.7.1 Aspen Company Details

      • 11.7.2 Aspen Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Aspen Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.7.4 Aspen Vitamin K Antagonists (VKA) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Bayer

      • 11.8.1 Bayer Company Details

      • 11.8.2 Bayer Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Bayer Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.8.4 Bayer Vitamin K Antagonists (VKA) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Daiichi Sankyo

      • 11.9.1 Daiichi Sankyo Company Details

      • 11.9.2 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.9.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Otsuka

      • 11.10.1 Otsuka Company Details

      • 11.10.2 Otsuka Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Otsuka Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.10.4 Otsuka Vitamin K Antagonists (VKA) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Sanofi

      • 11.11.1 Sanofi Company Details

      • 11.11.2 Sanofi Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Sanofi Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.11.4 Sanofi Vitamin K Antagonists (VKA) Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 AstraZeneca

      • 11.12.1 AstraZeneca Company Details

      • 11.12.2 AstraZeneca Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 AstraZeneca Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.12.4 AstraZeneca Vitamin K Antagonists (VKA) Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Pfizer

      • 11.13.1 Pfizer Company Details

      • 11.13.2 Pfizer Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Pfizer Vitamin K Antagonists (VKA) Main Business and Markets Served

      • 11.13.4 Pfizer Vitamin K Antagonists (VKA) Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Vitamin K Antagonists (VKA) Market Outlook by Types and Applications to 2028

    • 12.1 Global Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Vitamin K Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Injection Vitamin K Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global VTE Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global AF Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Vitamin K Antagonists (VKA) Market Analysis and Outlook to 2028

    • 13.1 Global Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.2 UK Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.5 France Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.3 India Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Vitamin K Antagonists (VKA) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Vitamin K Antagonists (VKA)

    • Figure of Vitamin K Antagonists (VKA) Picture

    • Table Global Vitamin K Antagonists (VKA) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Vitamin K Antagonists (VKA) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Vitamin K Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Vitamin K Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global VTE Consumption and Growth Rate (2017-2022)

    • Figure Global ACS/MI Consumption and Growth Rate (2017-2022)

    • Figure Global AF Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Table North America Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure United States Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Canada Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table Europe Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure Germany Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure UK Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Spain Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure France Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Italy Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Finland Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Norway Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Poland Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Russia Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table APAC Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure China Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Japan Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure India Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table South America Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure Brazil Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Chile Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Peru Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table GCC Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure Bahrain Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Oman Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table Africa Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure Nigeria Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table Oceania Vitamin K Antagonists (VKA) Consumption by Country (2017-2022)

    • Figure Australia Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Vitamin K Antagonists (VKA) Consumption and Growth Rate (2017-2022)

    • Table Lilly Company Details

    • Table Lilly Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lilly Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Lilly Vitamin K Antagonists (VKA) Product Portfolio

    • Table Bristol-Myers Squibb Company Details

    • Table Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Portfolio

    • Table The Medicines Company Company Details

    • Table The Medicines Company Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Medicines Company Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table The Medicines Company Vitamin K Antagonists (VKA) Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Portfolio

    • Table Genentech (Roche) Company Details

    • Table Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech (Roche) Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Genentech (Roche) Vitamin K Antagonists (VKA) Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Johnson & Johnson Vitamin K Antagonists (VKA) Product Portfolio

    • Table Aspen Company Details

    • Table Aspen Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aspen Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Aspen Vitamin K Antagonists (VKA) Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Bayer Vitamin K Antagonists (VKA) Product Portfolio

    • Table Daiichi Sankyo Company Details

    • Table Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Daiichi Sankyo Vitamin K Antagonists (VKA) Product Portfolio

    • Table Otsuka Company Details

    • Table Otsuka Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Otsuka Vitamin K Antagonists (VKA) Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Sanofi Vitamin K Antagonists (VKA) Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table AstraZeneca Vitamin K Antagonists (VKA) Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Vitamin K Antagonists (VKA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Vitamin K Antagonists (VKA) Main Business and Markets Served

    • Table Pfizer Vitamin K Antagonists (VKA) Product Portfolio

    • Figure Global Oral Vitamin K Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Vitamin K Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VTE Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AF Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Table North America Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure United States Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure Germany Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure China Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Vitamin K Antagonists (VKA) Consumption Forecast by Country (2022-2028)

    • Figure Australia Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Vitamin K Antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US